Ab&B Bio-Tech Updates Board Composition and Committee Assignments

Bulletin Express05-27

Ab&B Bio-Tech CO., LTD. JS announced the latest configuration of its Board of Directors and the corresponding committee assignments. The Board now comprises eight members, including three executive directors, two non-executive directors, and three independent non-executive directors.

Executive leadership is headed by Chairman Mr. An Youcai, who also chairs the Strategy Committee. The other executive directors are Ms. Li Runxiang and Mr. He Yiming.

Non-executive representation consists of Mr. Yu Jianlin and Mr. Du Mu.

Independent oversight is provided by Mr. Li Xiangming, Mr. Li Jianjun, Mr. Chen Chengbei, and Ms. Lui Mei Ka.

Committee leadership is structured as follows: • Audit Committee – chaired by Mr. Li Jianjun • Remuneration and Appraisal Committee – chaired by Mr. Chen Chengbei • Nomination Committee – chaired by Mr. Li Xiangming • Strategy Committee – chaired by Mr. An Youcai

The disclosure reiterates Ab&B Bio-Tech’s adherence to corporate governance guidelines by clearly defining responsibilities across its four key committees.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment